Since RLIP76 plays a requisite role in the development of tumor, a clear understanding of the interaction at the molecular level could potentially open up new therapeutic avenues for the treatment of malignant meningiomas. The gene discussed is RALBP1; the disease is Anaplastic (Malignant) Meningioma.